• Overview
• COVID Guidelines
• 2022 Agenda
• Download the Agenda
• Speaking Faculty
• Who Attends
• 2022 Sponsors
• Sponsorship Opportunities
• Partners/Media
• IO360˚ Newsletter & Women in Leadership
• Event News
• Venue Information
• Testimonials
• Photo Gallery
• Registration Fees
• Register Here
• Follow us on Linkedin

Register Here

Overview

IO360˚convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

---

 

The 8th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

1. Access to KOLs driving the science
2. Partnership opportunities with all stakeholders in Immuno-Oncology
3. Presentations on the latest data impacting the science, clinical and business advancements in Immuno-Oncology

Keynotes

Key Topic Areas

Featured Speakers

 

Join the conversation early and become part of the IO360° community by following us on LinkedIn and by following the conference hashtag #IO360nyc. If you are interested in participating in the 8th Annual Immuno-Oncology 360° 2022 program, please contact us at service@tcfllc.org. Thank you.

Sincerely,​

Kate Woda Conference Director	Valerie Bowling Executive Director
Meredith Sands Executive Director, Strategic Partnerships	Elizabeth Bard Senior Strategic Partnership Manager
Bre Bugbee Senior Marketing Manager	Adam Kolanko Strategic Partnership Manager
Madison Childs Client Success Manager	Danny McCarthy IO360° Writer/Editor

---

Testimonials

• "By bringing together groups such as scientists, investors, and experts in clinical trial design and logistics, it creates a forum where there’s quite a lot of folks participating who are not traditionally talking to one another on a daily basis."

  - Roy Baynes, MD, PhD, Merck

• "I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."

  - Jacqueline Karmel, Roche

• "Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."

  - Christine Ward, BMS

• "IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"

  - Jim Mansfield, PerkinElmer

• "Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"

  - Gilson Baia, PhD, Champions Oncology

• "Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an impressive speaking faculty."

  - Eileen Daniels, Nektar Therapeutics

• "Thank you for a great conference!"

  - Elena Spanjaard, Pfizer

• "Your team did a wonderful job in putting together an interesting and relevant program."

  - Lew Bender, Intensity Therapeutics

• "It was a great conference and I was happy to be a part of it."

  - Anna Pavlick, DO, MD, NYU Cancer Center